Soleno Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Soleno Therapeutics will hold its annual stockholder meeting virtually on June 5, 2025, to elect directors and ratify the appointment of its accounting firm.
NASDAQ
DEF: Soleno Therapeutics Announces FDA Approval of VYKAT XR and Sets Date for Annual Stockholders Meeting
Soleno Therapeutics announces FDA approval of VYKAT XR for Prader-Willi syndrome and sets the date for its annual stockholders meeting on June 5, 2025.
NASDAQ
Soleno Therapeutics is holding its annual meeting on June 6, 2024, to vote on the election of a director, ratification of its accounting firm, and approval of an amended equity incentive plan.